Navigation Links
SuperGen to Present at the C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference

DUBLIN, Calif., July 06, 2007 /PRNewswire-FirstCall/ -- SuperGen, Inc. today announced that Dr. Gregory Berk, Chief Medical Officer, will present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference on Thursday, July 12, 2007 at the Mandarin Oriental Hotel in New York City.

SuperGen's presentation at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference is scheduled to begin at 3:30 p.m. EDT. A live webcast of the presentation will be available on the Investor Relations section of the Company's Web site at http://www.supergen.com. The webcast will be archived for 90 days.

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.

    Contacts:

    SuperGen                                SuperGen

    Timothy L. Enns                         Mary M. Vegh

    S.V.P., Corporate Communications        Manager, Investor Relations

    & Business Development                  (925) 560-2845

    (925) 560-0100 x111                     

    

mary.vegh@supergen.com tenns@supergen.com

CONTACT: Timothy L. Enns, S.V.P., Corporate Communications & BusinessDevelopment, +1-925-560-0100, Ext. 111, , or Mary M.Vegh, Manager, Investor Relations, +1-925-560-2845, ,both of SuperGen tenns@supergen .com mary.vegh@supergen.com

Web site: http://www.supergen.com/

Ticker Symbol: (NASDAQ-NMS:SUPG)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Suppresses Critical Double-Stranded DNA Repair Protein, Rad51
2. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at AACR
3. The Past, Present and Future of HLA Typing
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Blood Monitoring & Cardiac Monitoring Devices Market Assessment & Forecast: 2015-2019" ... market for blood monitoring & cardiac monitoring devices was valued at ... 24,830.1 million by 2019 at a CAGR of 6.8% from 2015 ... Europe , Asia-Pacific , Latin ... Africa . The three major factors determining growth of the ...
(Date:2/9/2016)... , Feb. 9, 2016  Increasingly, health care ... their vital signs with wireless technology. With the Vios ... automate patient oversight and remotely detect problems before they ... signs across in-hospital environments. the United ... United States . --> The ...
(Date:2/9/2016)... , Feb. 9, 2016  Johnson & Johnson (NYSE: ... Markets Global Healthcare Conference on Tuesday, Feb. 23, at ... Dominic Caruso , Vice President, Finance & Chief Financial ... will represent the Company in a session scheduled at ... --> www.investor.jnj.com . --> This ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... 2016 , ... The recreational use of marijuana has been legal in Colorado ... lot of restrictions as to where they can smoke pot. , As ... cannabis “may not be consumed openly or publicly.” , Given the momentum of the ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... staff helped give free oral screenings to 150 children in kindergarten through third ... The College of Dental Medicine joined Chinese American Dental Society of Southern California ...
(Date:2/10/2016)... TN (PRWEB) , ... February 09, 2016 , ... ... to sports concussion, yet the cause of injury may be one of many ... two-day advanced PT Continuing Education Course , Mastering Rehab Solutions for ...
(Date:2/9/2016)... ... 09, 2016 , ... Center for Autism and Related Disorders ... spectrum disorder (ASD). Beginning Jan. 1, 2016, Medicaid is covering autism treatment in ... key to providing effective treatment for individuals with ASD. Now, over 1,800 low-income ...
(Date:2/9/2016)... ... 2016 , ... URise Products announces today an Indiegogo campaign ... Walker. Made entirely in the USA, the StandUp Walker is one of the ... novel patent-pending design offers 2-in-1 benefits of a stand-assist device combined with ...
Breaking Medicine News(10 mins):